Stay updated with breaking news from News companies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Theres a greek devotion to the facemask, new exhibition in japan designed to pay homage to mask wearing culture and sport to european champions by munich face actually did the german side are looking to extend their back or Champions League winning. Streak to 16 matches the race to roll out a corona virus vaccine is exaggerating with more pharmaceutical companies, seeking emergency approval fines and biome tackle, seeking european regulate tree approval to declare their joint covert. 19 shot safe to use. The review is due to be finished by december, the 29th. Well that means it could be rolled out before the end of this month in england, month long stay at home, order is due to expire. Later politicians are set to vote on new tiered restrictions to replace it, but m. P. s in the government, conservative party are divided on whether to support the proposals. Thats as the Econom ....
Will it work . One of the main incumbents, good rx, shares their answer to the new competition. The bitcoin rally continues, but for how long . Brad darling house will have his take later this hour. Tech share is leading the market higher as more covid restrictions, staying at home for the foreseeable future. Scientists are racing to make advances on the vaccine front, but there is a long winter ahead. Joining us now is abigail doolittle, taking a look at the Market Movers of the day. A lot of conflicting strands. How does it add up . Yesterday, we had the bearish , the risk off news about Public Schools closing. The Biggest School systems in the u. S. Closing on the virus. We have hospitalizations at a record high in the u. S. Stocks yesterday sold off. Today, they rallied. They started in the red, and were flat on the d ....
A very warm welcome to all of you us drug for modern us says its applying for emergency approval of its covert 1000 vaccine in both europe and the united states. Well that could lead to distribution in the u. S. As soon as december, the company says full trial results show its vaccine was 94 percent effective with no serious side effects while the filing this stuff mcgurn is product to be the 2nd vaccine likely to receive special authorization after the one developed by by sir and beyond tech. Well joining me now is yanis announces he is with the european a Public Health alliance and is a board member of European Medicines Agency is known as e m a, which is dealing with murder and as a request for authorization. A very good evening, sir. Why do you think were there now will be granted approval by the way. Good evening. It is hard to tell and obviously i dont speak o ....